OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2021
(4)
2023
(3)
2022
(3)
2025
(2)
2024
(2)
2020
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
TMEM41B is a pan-flavivirus host factor.
Not available
S-EPMC7553181
|
biostudies-literature
Cite
TMEM41B Is a Pan-flavivirus Host Factor.
Not available
S-EPMC7954666
|
biostudies-literature
Cite
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry.
Not available
S-EPMC8623001
|
biostudies-literature
Cite
ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry.
Not available
S-EPMC3252425
|
biostudies-literature
Cite
Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm <i>Riboviria</i>: kingdom <i>Orthornavirae</i>: phylum <i>Negarnaviricota</i>).
Not available
S-EPMC10721048
|
biostudies-literature
Cite
Global anaesthesia practice using inguinal hernia surgery as a tracer condition: a secondary analysis of an international prospective cohort study.
Not available
S-EPMC12519944
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets